Analystreport

bluebird bio Inc (NASDAQ: BLUE) had its "buy" rating re-affirmed by analysts at William Blair.

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview